Author Topic: (EAN 2018) MS progression may be best monitored w/MRIs of both brain and spine  (Read 101 times)

0 Members and 2 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9822
  • MS diagnosed 1980
  • Location: Pacific Northwest

Multiple Sclerosis News Today (June 21, 2018) reports on a paper presented at the 2018 EAN (European Academy of Neurology) conference, giving evidence that there can be gadolinium-enhancing lesions in the spine but not in the brain of some persons with MS and  favoring the use of both brain and spinal MRIs in the assessment of MS:

https://multiplesclerosisnewstoday.com/2018/06/21/ean2018-measuring-disease-activity-in-multiple-sclerosis-best-with-brain-and-spinal-mristudy-says/?utm_source=Multiple+Sclerosis&utm_campaign=86a96fa6cc-RSS_US_EMAIL_CAMPAIGN&utm_medium=email&utm_term=0_b5fb7a3dae-86a96fa6cc-71286581]
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
105 Views
Last post April 28, 2017, 02:53:29 pm
by agate
0 Replies
89 Views
Last post March 17, 2019, 11:18:38 am
by agate
0 Replies
37 Views
Last post May 16, 2021, 09:22:46 pm
by agate
0 Replies
22 Views
Last post May 21, 2022, 09:59:19 pm
by agate
0 Replies
18 Views
Last post July 12, 2022, 09:26:17 pm
by agate